Pulmonary Hypertension in Obstructive Sleep Apnea: Is it Clinically Significant? a Critical Analysis of the Association and Pathophysiology
Open accessThe DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
The development of pulmonary hypertension is a poor prognostic sign in patients with obstructive sleep apnea (OSA) and affects both mortality and quality of life. Although pulmonary hypertension in OSA is traditionally viewed as a result of apneas and intermittent hypoxia during sleep, recent studies indicate that neither of these factors correlates very well with pulmonary artery pressure. Human data show that pulmonary hypertension in the setting of OSA is, in large part, due to left heart dysfunction with either preserved or diminished ejection fraction. Longstanding increased left heart filling pressures eventually lead to pulmonary venous hypertension. The combination of hypoxic pulmonary vasoconstriction and pulmonary venous hypertension with abnormal production of mediators will result in vascular cell proliferation and aberrant vascular remodeling leading to pulmonary hypertension. These changes are in many ways similar to those seen in other forms of pulmonary hypertension and suggest shared mechanisms. The majority of patients with OSA do not receive a diagnosis and are undertreated. Appreciating the high prevalence and understanding the mechanisms of pulmonary hypertension in OSA would lead to better recognition and management of the condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PH related to OSA is generally mild in the absence of additional cardiopulmonary disease, with average mean pulmonary artery pressure between 25 and 30 mm Hg and rarely exceeding 35 mm Hg. 43”
From Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2021) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., & Mohsenin, V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043104 · Cited by 3,004
Self-citationThe epidemiology of adult obstructive sleep apnea
Punjabi, N. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200709-155mg · Cited by 2,361 · cited 1×
“An estimated 40 million Americans experience OSA, with a 3%–7% prevalence among men and a 2%–5% prevalence among women.(5) OSA is an independent risk factor for systemic hypertension, stroke, myocardial ischemia, congestive heart failure, arrhythmias, and sudden cardiac death.”
BackgroundGottlieb, D. J., Yenokyan, G., Newman, A. B., O'Connor, G. T., Punjabi, N. M., Quan, S. F., Redline, S., Resnick, H. E., Tong, E. K., Diener-West, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.901801 · Cited by 1,551
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Riociguat for the treatment of pulmonary arterial hypertension
Ghofrani, H.-A., Galiè, N., Grimminger, F., Grünig, E., Humbert, M., Jing, Z.-C., Keogh, A. M., Langleben, D., Kilama, M. O., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209655 · Cited by 1,346 · cited 8×
“Chronic intermittent hypoxia causes suppression of eNOS and impairment of endothelial-dependent vasodilation by an NF-κB-dependent mechanism.70 In humans with OSA, alveolar NO is reduced.71 Furthermore, circulating cGMP is reduced in patients with OSA with endothelial dysfunction.72 Riociguat, a stimulator of soluble…”
BackgroundInfluential
Cited by
Yeghiazarians, Y., Jneid, H., Tietjens, J. R., Redline, S., Brown, D. L., El-Sherif, N., Mehra, R., Bozkurt, B., Ndumele, C. E., Somers, V. K., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000988 · Cited by 1,431
Zoccali, C., Vanholder, R., Massy, Z. A., Ortiz, A., Sarafidis, P., Dekker, F. W., Fliser, D., Fouque, D., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 444
Tietjens, J. R., Claman, D., Kezirian, E. J., De Marco, T., Mirzayan, A., Sadroonri, B., Goldberg, A. N., Long, C., Gerstenfeld, E. P., & Yeghiazarians, Y. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010440 · Cited by 397
“Signaling pathways implicated in hypoxic vasoconstriction in PH include nitric oxide, endothelin, angiopoietin-1, serotonin, and NADPH-oxidase.(64) Chronic hypoxia activates additional inflammatory pathways resulting in pulmonary vascular remodeling and, eventually, irreversible increases in pulmonary vascular resista…”
BackgroundSleep Disordered Breathing and Cardiovascular Disease
Cowie, M. R., Linz, D., Redline, S., Somers, V. K., & Simonds, A. K. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.048 · Cited by 311
Obstructive sleep apnea: personal, societal, public health, and legal implications
Morsy, N. E., Farrag, N. S., Zaki, N. F. W., Badawy, A. Y., Abdelhafez, S. A., El‐Gilany, A., shafey, M. M. E., Pandi-Perumal, S. R., Spence, D. W., & BaHammam, A. S. (2019) · Reviews on Environmental Health · doi:10.1515/reveh-2018-0068 · Cited by 155
“In one study a multivariate linear regression analysis with adjustment for age, sex, body mass index, and the AHI, AHI during NREM (AHINREM) compared to AHI during REM (AHIREM) was found to be considerably more closely linked to psychomotor vigilance test lapses than AHI during REM.”
BackgroundInfluentialA clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease
Maeder, M. T., Schoch, O. D., & Rickli, H. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s74703 · Cited by 127
OSA and Chronic Respiratory Disease: Mechanisms and Epidemiology
Locke, B. W., Lee, J. J., & Sundar, K. M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095473 · Cited by 113
Kikuchi, N., Satoh, K., Kurosawa, R., Yaoita, N., Al-Mamun, M. E., Siddique, M. A. H., Omura, J., Satoh, T., Nogi, M., Sunamura, S., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033113 · Cited by 100
Triantafyllopoulos, G. K., Soranoglou, V. G., Memtsoudis, S. G., Sculco, T. P., & Poultsides, L. A. (2017) · The Journal of Arthroplasty · doi:10.1016/j.arth.2017.11.040 · Cited by 97
The Effects of Obstructive Sleep Apnea on the Cardiovascular System: A Comprehensive Review
Dicaro, M. V., Lei, K., Yee, B., & Tak, T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113223 · Cited by 118
“Each of these pathways causes pulmonary vascular remodeling via the proliferation of smooth muscle cells and asymmetric neointimal hyperplasia [66,88].”
BackgroundKim, D., & George, M. P. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.12.002 · Cited by 77
The epidemiology of obstructive sleep apnoea and cardiovascular disease
Sarkar, P., Mukherjee, S., Chai‐Coetzer, C. L., & McEvoy, R. D. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.12.56 · Cited by 67
“There are data from observational studies suggesting that CPAP treatment of OSA in patients with pulmonary hypertension improves right heart function and reduces pulmonary pressures (81,82).”
MethodObstructive Sleep Apnea and Pulmonary Hypertension in Children
Ingram, D. G., Singh, A., Ehsan, Z., & Birnbaum, B. F. (2017) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2017.01.001 · Cited by 70
Pellikaan, K., Rosenberg, A. G. W., Kattentidt‐Mouravieva, A. A., Kersseboom, R., Bos‐Roubos, A. G., Veen-Roelofs, J. M. C., Wieringen, N. V. A.-V., Hoekstra, F. M. E., van den Berg, S. A. A., van der Lely, A. J., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa621 · Cited by 62
“Central sleep apnea, obstructive sleep apnea, and obesity hypoventilation syndrome can lead to pulmonary hypertension (31, 32), DM2 (33), and a further increase in obesity (34) and CV risk (35–38).”
BackgroundAssociation between obstructive sleep apnea and cardiovascular diseases
Li, Y. E., & Ren, J. T. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022084 · Cited by 68
“The main culprit for pathogenesis of PH in the OSA condition is thought to be nocturnal episodic hypoxia, which reflexively triggers pulmonary arteriolar constriction resulting in sudden, reversible increase in pulmonary artery pressures, involving changes in endothelin, nitric oxide, angiopoietin-1, serotonin and NAD…”
BackgroundSleep Apnea Increases Ninety-Day Complications and Cost Following Primary Total Joint Arthroplasty
Vakharia, R. M., Cohen-Levy, W. B., Vakharia, A. M., Donnally, C. J., Law, T. Y., & Roche, M. W. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.12.018 · Cited by 46
Pulmonary hypertension: diagnostic and therapeutic challenges
Fares, W. H., & Bazan, I. S. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s74881 · Cited by 61
Self-citationBrittain, E. L., Thenappan, T., Huston, J., Agrawal, V., Lai, Y., Dixon, D., Ryan, J. J., Lewis, E. F., Redfield, M. M., Shah, S. J., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001079 · Cited by 36
Imran, T. F., Ghazipura, M., Liu, S., Hossain, T., Ashtyani, H., Kim, B., Michael Gaziano, J., & Djoussé, L. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9548-5 · Cited by 36
“constrictors, had increased expression when placed in a hypoxic environment [33].”
BackgroundPrabhahar, A., Batta, A., Hatwal, J., Kumar, V., Ramachandran, R., & Batta, A. (2025) · World Journal of Transplantation · doi:10.5500/wjt.v15.i1.97458 · Cited by 37
“OSA decreases NO production due to repeated episodes of hypoxia, and is a risk factor for pulmonary arterial hypertension[51,52].”
Voulgaris, A., Archontogeorgis, K., Steiropoulos, P., & Παπάνας, Ν. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200318103553 · Cited by 48
Non-Conventional Risk Factors: “Fact” or “Fake” in Cardiovascular Disease Prevention?
Cimmino, G., Natale, F., Alfieri, R., Cante, L. C., Covino, S., Franzese, R., Limatola, M., Marotta, L., Molinari, R., Mollo, N., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11092353 · Cited by 38
“Hypoxia and hypercapnia induce arteriolar vasoconstriction in the short term and vascular remodeling in the long term that could lead to an irreversible increase in pulmonary vascular resistance and the development of pulmonary hypertension [167].”
BackgroundShin, C. H., Grabitz, S. D., Timm, F. P., Mueller, N., Chhangani, K., Ladha, K. S., Devine, S., Kurth, T., & Eikermann, M. (2017) · BMC Anesthesiology · doi:10.1186/s12871-017-0361-z · Cited by 28
“The SPOSA is a weighted model containing comorbidity and demographic variables known to be associated with OSA, including: chronic pulmonary disease [35], congestive heart failure [5, 6], diabetes [7], dyslipidemia [36, 37], hypertension [3, 38], atrial fibrillation [39, 40], liver disease [41], coronary artery diseas…”
BackgroundKasai, T., Kohno, T., Shimizu, W., Ando, S., Joho, S., Osada, N., Kato, M., Kario, K., Shiina, K., Tamura, A., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0489 · Cited by 28
Karuga, F. F., Kaczmarski, P., Szmyd, B. M., Białasiewicz, P., Sochal, M., & Gabryelska, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175008 · Cited by 28
“, distortion of pulmonary ultrastructure causing ventilation–perfusion mismatch with progressing alveolar hypoventilation and reduction in cross-sectional areal of pulmonary capillaries [72].”
BackgroundSleep apnoea, gut dysbiosis and cognitive dysfunction
Deyang, T., Baig, M., Dolkar, P., Hediyal, T. A., Rathipriya, A. G., Bhaskaran, M., Pandi-Perumal, S. R., Monaghan, T. M., Mahalakshmi, A. M., & Chidambaram, S. B. (2023) · FEBS Journal · doi:10.1111/febs.16960 · Cited by 27
“The main mechanism behind OSA-related pulmonary hypertension is considered to be the constriction of pulmonary arterioles induced by hypoxia, mediated by various signaling pathways involving nitric oxide, endothelin, angiopoietin-1, serotonin and NADPH-oxidase [79].”
BackgroundChung, K. S., Kim, Y. S., Kim, S. I., Kim, H. Y., Lee, S. M., Seo, J. B., Oh, Y., Jung, J. Y., Lee, S.-D., & Korean Obstructive Lung Disease study group (2016) · PLoS ONE · doi:10.1371/journal.pone.0154584 · Cited by 25
“Obstructive sleep apnea is related with higher PA pressure and PH is a poor prognostic sign in patients with obstructive sleep apnea.[43]”
BackgroundIturriaga, R., & Castillo‐Galán, S. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0995-y · Cited by 27
Fortuni, F., Dietz, M. F., Butcher, S. C., Prihadi, E. A., van der Bijl, P., Marsan, N. A., Delgado, V., & Bax, J. J. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.09.022 · Cited by 22
Sleep Deficiency in Obstructive Sleep Apnea
Adekolu, O., & Zinchuk, A. V. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.02.013 · Cited by 28
Exercise Testing in the Risk Assessment of Pulmonary Hypertension
Forbes, L. M., Bull, T., Lahm, T., Make, B. J., & Cornwell, W. K. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.04.013 · Cited by 23
Kikuchi, N., Satoh, K., Satoh, T., Yaoita, N., Siddique, M. A. H., Omura, J., Kurosawa, R., Nogi, M., Sunamura, S., Miyata, S., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313267 · Cited by 21
“Our findings demonstrate that (1) circulating serum SeP levels were significantly higher in patients with PAH compared with controls, (2) the rates of all-cause death and lung transplantation were significantly higher in patients with PAH with higher serum SeP levels than in those with lower serum SeP levels, (3) abso…”
ResultLitvin, A. Y., Chazova, I. E., Elfimova, E. M., Pevzner, A. V., Poluektov, M. G., Danilov, N. M., Mikhailova, O. O., & Владимировна, А. А. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-3-6-27 · Cited by 24
Perioperative sleep apnea: a real problem or did we invent a new disease?
Zaremba, S., Mojica, J. E., & Eikermann, M. (2016) · F1000Research · doi:10.12688/f1000research.7218.1 · Cited by 21
“In the general population, OSA is a risk factor for diabetes 17 and cardiovascular diseases including cardiac arrhythmias 18,19 , myocardial infarction 20 , pulmonary hypertension 21 , systemic hypertension 19,22 , heart failure 19 , renal disease 23 , stroke, and death 24 .”
BackgroundThe emerging role of microRNAs in hypoxia-induced pulmonary hypertension
Mohsenin, V. (2016) · Sleep And Breathing · doi:10.1007/s11325-016-1351-y · Cited by 19
“in the common pathophenotype of PH [35].”
Self-citationSleep Apnea: A Geriatric Syndrome
Morley, J. E., Sanford, A. M., & Bourey, R. E. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.08.020 · Cited by 20
Diagnosis and management of pulmonary hypertension related to chronic respiratory disease
Krompa, A., & Marino, P. S. (2022) · Breathe · doi:10.1183/20734735.0205-2022 · Cited by 20
Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension
Satoh, K., Kikuchi, N., Satoh, T., Kurosawa, R., Sunamura, S., Siddique, M. A. H., Omura, J., Yaoita, N., & Shimokawa, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124081 · Cited by 19
“, hypoxia [3], infection [4], smoking [5], air pollution [6], daily diet [7], and medications [8]), as well as volume overload, due to heart disease [9], and inflammation, due to collagen disease [10], are involved in the development of PAH [11].”
BackgroundTan, J. W. C., Leow, L. C., Wong, S., Khoo, S. M., Kasai, T., Kojodjojo, P., Duong‐Quy, S., Lee, C. P., Chirakalwasan, N., Li, H., et al. (2022) · European Cardiology Review · doi:10.15420/ecr.2021.59 · Cited by 17
“Sources: Javaheri et al. 2017, Doumit and Prasad 2016, Garvey et al. 2015, Romero-Corral et al. 2010 and Kholdani et al. 2015.6–10 Table 2: STOP-Bang Questionnaire Interpretation”
InfluentialObstructive Sleep Apnea and Right Ventricular Remodeling: Do We Have All the Answers?
Tadić, M., & Cuspidi, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12062421 · Cited by 18
“Nevertheless, even in the absence of other known cardiopulmonary disorders, permanent pulmonary hypertension can develop in these patients [10], which can further induce the development of RV hypertrophy and dysfunction.”
BackgroundExercise Intolerance in Untreated OSA
Elbehairy, A. F., Geneidy, N. M., Hoshy, M. S. E., El-Sanhoury, D., Elfeky, M. K., Elhameed, A. A., Horsley, A. R., O’Donnell, D. E., Abd-Elwahab, N. H., & Mahmoud, M. I. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.09.027 · Cited by 13
Miles, S., Ahmad, W., Bailey, A., Hatton, R., Boyle, A., & Collins, N. J. (2016) · Congenital Heart Disease · doi:10.1111/chd.12369 · Cited by 12
Rovere, M. T. L., Fanfulla, F., Taurino, A. E., Bruschi, C., Maestri, R., Robbi, E., Maestroni, R., Pronzato, C., Pin, M., D’Armini, A. M., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.02.112 · Cited by 13
Neagoş, A., Dumitru, M., Neagoș, C. M., Mitroi, M. R., & Vrînceanu, D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11185347 · Cited by 12
“In this stage, the body response will promote aberrant vascular remodeling and the installment of persistent pulmonary hypertension [17,18].”
BackgroundPulmonary hypertension: the importance of correctly diagnosing the cause
Mehta, S., & Vachiéry, J. (2016) · European Respiratory Review · doi:10.1183/16000617.0104-2016 · Cited by 13
Evaluating suspected pulmonary hypertension: A structured approach
Bhatnagar, A., Wiesen, J., Dweik, R. A., & Chaisson, N. F. (2018) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.85a.17065 · Cited by 12
Lantz, B. J., Moriwaki, M., Oyebamiji, O., Guo, Y. P., & Bosc, L. V. G. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2023.1304732 · Cited by 12
Obstructive sleep apnea, the NLRP3 inflammasome and the potential effects of incretin therapies
Wei, M., Teske, J. A., Mashaqi, S., & Combs, D. (2025) · Frontiers in Sleep · doi:10.3389/frsle.2024.1524593 · Cited by 12
Damianos, A., Kulandavelu, S., Chen, P., Nwajei, P., Batlahally, S., Sharma, M., Álvarez-Cubela, S., Domínguez‐Bendala, J., Zambrano, R. A. P., Huang, J., et al. (2022) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00708.2021 · Cited by 10
Obstructive Sleep Apnea and Pulmonary Hypertension: A Review of Literature
Shah, F. A., Moronta, S., Braford, M. B., & Greene, N. (2021) · Cureus · doi:10.7759/cureus.14575 · Cited by 18
“Similar effects occur with NO in the setting of chronic intermittent hypoxia with suppression of eNOS and impaired vasodilation of the endothelium, mediated by NF-kB (nuclear factor kappa B) mechanisms [5].”
BackgroundInfluentialMacek, P., Poręba, M., Stachurska, A., Martynowicz, H., Mazur, G. J., Gać, P., & Poręba, R. (2022) · Brain Sciences · doi:10.3390/brainsci12030331 · Cited by 10
“Pulmonary hypertension is a hemodynamic and pathophysiological state that can be found among patients with OSA [9].”
BackgroundGillespie, M. L., Spring, M. R., Cohen, R. T., & Klings, E. S. (2022) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2022.101602 · Cited by 13
Jen, R., Orr, J. E., Gilbertson, D., Fine, J. M., Li, Y., Wong, D. J., Bosompra, N., Hopkins, S. R., Raisinghani, A., & Malhotra, A. (2020) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2020.103557 · Cited by 8
“On the other hand, association of vasoreactivity with severity of OSA including AHI and T < 90 % were observed, as supported by prior studies (Kholdani et al., 2015).”
ResultNarrative review of sleep and pulmonary hypertension
Louise, B. J., Carys, F., & Marino, P. S. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-cus-2020-004 · Cited by 7
Wang, W. J., Yuan, F., Hou, Y., Yang, D., Zhang, S., & Lu, H. (2020) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2020.09.043 · Cited by 8
Management of Pulmonary Hypertension Associated with Chronic Lung Disease
Blanco, I., Hernández‐González, F., García, A. A., Torres‐Castro, R., & Barberà, J. A. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0043-1770121 · Cited by 7
Posada, A. M., Isaza, N., Centanaro, O. P. P., Rondón, M., & Martínez, P. H. (2019) · High Altitude Medicine & Biology · doi:10.1089/ham.2017.0149 · Cited by 7
“The increase in SRBD leads to higher morbidity, as it has been demonstrated that these pediatric patients show higher rates of pulmonary hypertension, deficits in neurocognitive performance, behavioral impairments, and decreased school performance (Kholdani et al., 2015; Trosman and Trosman, 2017).”
Hajipour, M., Gonzalo Labarca, T., Ayas, N., & Azarbarzin, A. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2618-7422 · Cited by 7
“61 Overall, 27 to 30% of OSA patients without left ventricular dysfunction or hypoxemic lung disease develop PH. 62 Notably, OSA patients with PH experience a lower quality of life and higher mortality compared with those without PH. 63 Obesity Hypoventilation Syndrome Pathophysiology OHS is a disorder characterized b…”
InfluentialRight Ventricular Response to Acute Hypoxia Exposure: A Systematic Review
Mamazhakypov, A., Sartmyrzaeva, M., Kushubakova, N. A., Duishobaev, M., Maripov, A., Sydykov, A. S., & Шогаибович, С. А. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.786954 · Cited by 6
Sharma, S., Stine, J. G., Verbeek, T., & Bezinover, D. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.07.020 · Cited by 5
Connolly, J. E., Genuardi, M. V., Mora, J. I., & Prenner, S. B. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10876 · Cited by 6
Obstructive Sleep Apneas and Cardiovascular Diseases
Castiglione, V., Morfino, P., Fabiani, I., Gentile, F., Airò, E., Volpi, B., Cardinale, D. M., Passino, C., Giannoni, A., & Emdin, M. (2026) · Clocks & Sleep · doi:10.3390/clockssleep8020028 · Cited by 7
“Intermittent hypoxia promotes pulmonary vasoconstriction, inflammation, and vascular remodelling, increasing pulmonary vascular resistance [70].”
Jain, S., Yingchoncharoen, P., & NUGENT, K. M. (2023) · Cardiology in Review · doi:10.1097/crd.0000000000000564 · Cited by 5
Sleep Deficiency in Obstructive Sleep Apnea
Adekolu, O., Ahsan, M., Anwar, A. I., & Zinchuk, A. V. (2024) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2024.08.002 · Cited by 4
Akbari, A., Raji, H., Islampanah, M., Barati, S., Davoodian, N., Aminizadeh, S., Baniassad, S., Amini, M., & Baniasad, A. (2025) · Sleep And Breathing · doi:10.1007/s11325-025-03280-9 · Cited by 4
“Endo - thelial dysfunction can lead to increased vascular resistance and further exacerbation [ 13 ].”
Anesthetic Management of the Adult Patient with Concomitant Cardiac and Pulmonary Disease
Radosevich, M. A., & Brown, D. R. (2016) · Anesthesiology Clinics · doi:10.1016/j.anclin.2016.06.001 · Cited by 5
“More recently, left heart dysfunction and elevated pulmonary venous pressures have been implicated as a cause of pulmonary hypertension in this group.(13) Obesity hypoventilation syndrome (OHS) is associated not only with episodes of”
BackgroundShanmuganathan, A., Advita, G., Meenakshi, N., Ragulan, R., Ganga, N., & Pukazhenthi, K. (2018) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20180980 · Cited by 4
“ILD has a higher prevalence of PAH (30-40%) which is mild to moderate due to parenchymal and vascular remodelling.(5) PAH was found in 12-34% of patients diagnosed with obstructive sleep apnea.”
BackgroundAgarwal, B., Yadav, P., Roychoudhury, A., Bhutia, O., Goswami, D., & Shukla, G. (2021) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2021.01.015 · Cited by 4
Cardiovascular Complications of Obstructive Sleep Apnea in the Intensive Care Unit and Beyond
Wahab, A., Chowdhury, A. R., Jain, N. K., Surani, S., Mushtaq, H. A., Khedr, A., Mir, M., Jama, A. B., Rauf, I., Jain, S., et al. (2022) · Medicina · doi:10.3390/medicina58101390 · Cited by 8
“The proposed mechanisms by which OSA can cause PH include hypoxic pulmonary arteriolar vasoconstriction [85] and activation of inflammatory pathways due to chronic sustained hypoxia leading to vascular remodeling and ultimate irreversible increase in pulmonary vascular resistance and right ventricular (RV) dysfunction.”
BackgroundInfluentialCardiovascular Complications in Obstructive Sleep Apnea Syndrome
Resuli, A. S. (2019) · Multidisciplinary Cardiovascular Annals · doi:10.5812/mca.91534 · Cited by 4
Wang, S., Cui, H. Z., Meng, L., Wu, R., Tang, B., Zhu, C., Yu, Q., Huang, X., & Wang, S. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.05.190 · Cited by 4
Umeda, A., Miyagawa, K., Mochida-Saito, A., Takeda, H., Takeda, K., Okada, Y., & Gozal, D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.583735 · Cited by 7
A 59-Year-Old Woman With Shortness of Breath and Chest Pain
Duvvuri, P. D., Liu, J., & Bhardwaj, C. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.059 · Cited by 4
Sweed, R. A., Bedair, G. M. M., Shaban, A. Y., & Shaarwy, H. A. (2023) · Egyptian Journal of Bronchology · doi:10.1186/s43168-023-00219-0 · Cited by 3
“Another study reported that the severity of OSAHs correlated with pulmonary artery pressure [50].”
BackgroundPreoperative Considerations for Ambulatory Surgery: What Is New, What Is Controversial
Pai, S., Gloff, M. S., & Blitz, J. D. (2024) · Current anesthesiology reports · doi:10.1007/s40140-024-00616-1 · Cited by 3
“Affecting between 12 and 34% of obese patients, group 3 PH is thought to be related to chronic hypoventilation and/ or severe, untreated OSA [42 • ].”
Elsanan, M., Soliman, M. H., Meawad, B. M. N., Kandeel, N. T., Elshora, A. E., & Shehata, I. E. (2025) · Sleep And Breathing · doi:10.1007/s11325-025-03365-5 · Cited by 3
“The association between OSA and PH underscores the importance of OSA management in preventing adverse cardiovascular out - comes [34].”
Pulmonary arterial hypertension with cardiopulmonary comorbidities: is it a unique phenotype?
Zhang, M., Guo, X., Guo, W., Wang, Y., Xiao, Y., Han, J., Li, Y., Man, T., Li, J., Chen, Y., et al. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03833-4 · Cited by 2
“Because the development of PH in patients with OSAHS is associated with the cumulative effect of intermittent hypoxia [27].”
Quinaglia, T., Bakker, J. P., Baltzis, D., Chan, R. H., Manning, W. J., Wallace, M. L., Gongora, C. A., Gilman, H. K., Sama, S., Ho, T., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133788 · Cited by 2
Preoperative optimization of obstructive sleep apnea
Gumidyala, R., & Selzer, A. R. (2021) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000353 · Cited by 3
“and increased mortality.(75) In addition, signs of decompensated disease recognized on testing or physical examination and/or significant ventilation/gas exchange issues (resting hypoxemia or hypoventilation syndromes)(45) should prompt additional workup and a discussion with the surgeon, patient, and anesthesia team…”
BackgroundDyachenko, M. A., Simakova, M. A., Коростовцева, Л. С., Викторович, Б. М., Goncharova, N. S., Sviryaev, Y. V., & Моисеева, О. М. (2020) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2020-26-1-85-93 · Cited by 2
Sleep Apnea Combined with Pulmonary Hypertension in a Veteran Patient Population
Stark, P., & Chang, E. Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144634 · Cited by 3
“Forty million Americans have obstructive sleep apnea, including 3–7% of men and 2–5% of women [3].”
Khajouei, A. S., Nikaeen, F., Arzani, K., Sarrafzadegan, N., Nejati, M., & Behjati, M. (2020) · PubMed Central · Cited by 2
Governor, S., Essien, E., Agyekum, A. K., Ahsan, A., Wiesel, S., Khurana, D., El‐Kersh, K., Altaee, O., Otchere, P., & Dávila‐Román, V. G. (2026) · medRxiv · doi:10.64898/2026.01.20.26344489 · Cited by 1
Brooks, L., & Goudy, S. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-84733-3_3 · Cited by 2
Cardiovascular complications of sleep disordered breathing in the population with Down syndrome
Feeley, M., Cua, C. L., & Bush, D. S. (2022) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2022.101580 · Cited by 1
Impact of Pulmonary Hypertension on Renal Functions in Obstructive Sleep Apnea Syndrome
Uyar, M. (2023) · Southern Medical Journal · doi:10.14423/smj.0000000000001494 · Cited by 2
“Pulmonary hypertension (PH) in OSAS was detected as 12% to 70%, with higher mortality rates.(3,4) PH has several systemic consequences.”
BackgroundCardiopulmonary Complications of Klippel-Feil Syndrome: A Case Report
Bridglal, R.-A. M. (2024) · Cureus · doi:10.7759/cureus.67303 · Cited by 1
Huang, T., Liu, S., Ma, Y., Ma, L., & Dang, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-95793-2 · Cited by 3
Wang, T., Ma, J., & Song, Y. R. (2025) · Physiological Research · doi:10.33549/physiolres.935502 · Cited by 3
“HPV also contributes to a transient increase in PAP during sleep in patients suffering from obstructive sleep apnea [99].”
Cardiovascular complications in children with Down syndrome and sleep disordered breathing
Gocal, W. A., Zeder, K., Maron, B. A., & Isaiah, A. (2025) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2025.11.008 · Cited by 2
Obstructive Sleep Apnea and Arrhythmia: A Narrative Review of Arrhythmogenic Mechanisms
(Bercian), C. V. Z., Sitar-Tăut, A., Cozma, A., Buzdugan, E., Orasan, O. H., Lucaciu, R. L., Hangan, A. C., & Procopciuc, L. M. (2026) · Diagnostics · doi:10.3390/diagnostics16121885 · Cited by 1
“The transition from hypercapnia to eucapnia during apneic events rapidly restores normal atrial refractoriness, whereas atrial conduction time remains prolonged and this temporal mismatch establishes an electrical milieu conducive to the initiation of atrial fibrillation [75,76].”
Sleep Obstructive Apnea Syndrome
Argel, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-32487-1_29 · Cited by 1
Anesthesia Considerations in Obstructive Sleep Apnea
Valadez, A. A., Garduño-Chávez, B. I., Padilla, L. M., & Becerril-Gaitán, D. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-35225-6_20 · Cited by 1
Relationship between obstructive sleep apnea and pulmonary hypertension: past, present and future
Lenka, J., Foley, R. J., Metersky, M. L., & Salmon, A. (2024) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2024.2345684 · Cited by 2
“An estimated 40 million Americans have OSA, with a 3–7% prevalence in men and a 2–5% prevalence in women [9–11].”
BackgroundFrom cooperation to collapse: systemic failure in liver disease through a sociological lens
Wang, J., Lei, J., Harmsen, M. C., & Moshage, H. J. (2025) · Exploration of Digestive Diseases · doi:10.37349/edd.2025.100580 · Cited by 1
Yamdjeu, O. T., Begerow, A., Sommer, N., Diener, M., Weißmann, N., & Knoepp, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146857 · Cited by 2
“…to provoke high-altitude pulmonary edema (HAPE), a life-threatening condition [5–7], and also acquires pathophysiological significance in situations with prolonged hypoxia, e.g., at high altitudes or in lung diseases such as sleep apnea or chronic obstructive pulmonary disease (COPD) [8–10].”
Anesthesia, Mechanical Ventilation, and Hypoxic Pulmonary Vasoconstriction
Hagerman, A., & Licker, M. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-71301-6.00015-9 · Cited by 1
Hypopneas and Apneas as Physiological and Pathological Phenomena Throughout the Life Span
Giannoni, A., Borrelli, C., & Raglianti, V. (2016) · Springer eBooks · doi:10.1007/978-3-319-26354-0_3 · Cited by 2
Pulmonary Disease and Right Ventricular Function
Weiss, E., & Bădilă, E. (2018) · Springer eBooks · doi:10.1007/978-3-319-73764-5_22
Sleep-disordered Breathing and Cardiac Disorders
Thanedar, R., Sanzgiri, P., Shingare, V., Thanki, F., & Kudva, S. (2019) · International Journal of Head and Neck Surgery · doi:10.5005/jp-journals-10001-1371
Metadata
- Authors
- Kholdani, C., Fares, W. H., & Mohsenin, V.
- Affiliations
- Yale University (US)
- Corresponding author
- Mohsenin, Vahid
- Venue
- Pulmonary Circulation
- Publisher
- Wiley
- Published
- 2015-06
- Volume
- 5
- Issue
- 2
- Pages
- 220-227
- ISSN
- 2045-8932 (ISSN-L)
- 2045-8940
- PMC
- PMC4449234
- OpenAlex
- W2028630811
- Cited by
- 127
- References
- 89
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 11 · 2023: 15 · 2022: 17 · 2021: 9 · 2020: 12 · 2019: 10 · 2018: 9 · 2017: 6 · 2016: 10 · 2015: 1
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Pulmonary Circulation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Pharmacology (medical) › Apelin-related biomedical research
- Keywords
- pulmonary hypertension, obstructive sleep apnea, intermittent hypoxia, pulmonary venous hypertension, hypoxic pulmonary vasoconstriction, vascular remodeling, pulmonary artery pressure, prognosis, undertreatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.